CardioFocus HeartLight Post-Approval Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 250 participants.

Also called NCT03168659

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
  • CardioFocus Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03168659
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03168659. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06-16 (actual); primary completion 2026-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CardioFocus HeartLight Post-Approval Study
Intervention (Device)
HeartLight
Intervention (Procedure)
Ablation
Lead sponsor
CardioFocus (class: industry)

Record details

Record id
cardio:ct-nct03168659
Content hash
e89825fc6f5453e089bc73d30184ac12c07cd01106268c30a03151fabe37aca2